InvestorsHub Logo
Followers 67
Posts 3828
Boards Moderated 0
Alias Born 11/23/2014

Re: Afterhoursearnings3 post# 75888

Wednesday, 08/09/2017 8:55:04 PM

Wednesday, August 09, 2017 8:55:04 PM

Post# of 106839
Cash Flow will continue to grow along with revenues, profits, and assets as a whole. Financials say it all. I am not focused on ownership of anything I am focused on sustainable growth and a revenue streams continuing to grow and expand, which is happening. Very undervalued here can't wait for big money to jump in. I like where Tomas is going.

From last 10Q
Lab and Medical Equipment Capitalized Lease

On March 3, 2017, the Company entered into an asset sale and lease agreement (sale/leaseback transaction; “ Asset Sale and Lease Agreement” ), whereby the Company sold certain lab, medical and other equipment relating to the cell banking business for $400,000 and leased back the sold equipment over a three year term. The Company recorded the equipment and the capitalized lease liability at the estimated present value of the minimum lease payments of $619,825. This amount was reduced for lease payments made of $94,428 and increased by $253,309 as of June 30, 2017 due to the increase in the effective interest rate from 75.73% to 112.16% resulting in an estimated present value of minimum lease payment of $778,706 as of June 30, 2017. The $233,309 adjustment was recorded as an increase of non-cash interest expense.

The lease includes a base monthly rental payment of $20,000, due the first day of each calendar month. In addition, the Company is required to pay 2.3%, 22.5%, and 31.6% of revenues collected on deposits arising from cell banking business for years 1, 2 and 3, respectively. At the expiration of the lease, the Company is required to return all leased equipment and along with any maintenance records, logs, etc. in the Company’s possession to the lessor with no right of repurchase.

Seems we will start to see substantial increase in revs from cell banking going from 2.3% to 22.5% in year 2.
Balance sheet and P&L continue to strengthen while revs continue to grow faster as clinics are expanding.


Investing Activities

Net cash provided by investing activities was $640,000 for the six months ended June 30, 2017 represented proceeds from our equity investment of $140,000, $400,000 from sale of property and equipment and $100,000 receipt of deposit for the sale of our intellectual property and customers as compared to cash provided by investing activities of $65,000 from our equity investments and $500 from sale of property and equipment for the same period last year.


Imagine more clinics opened by year's end, and doing $2mil a quarter. I don't think $12 mil valuation is fair at all. Looking for some curveball news no one sees coming.

Everything is in my own opinion. Do what you think is right.